  Primary diffuse large B-cell lymphoma of the central nervous system ( CNS-DLBCL) is an aggressive disease with a poor prognosis. The status of the tumor immune microenvironment in CNS-DLBCL remains unclear. We investigated the prognostic implications of tumor-associated macrophages ( TAMs) , regulatory T-cells ( Tregs) , and indoleamine 2,3-dioxygenase ( IDO)